Gritstone bio Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Gritstone bio is a biotechnology research company based in Emeryville, California. It develops immunotherapies for cancer and infectious diseases, aiming to provoke a therapeutic immune response by directing the immune system to targeted antigens. The company began with tumor-specific neoantigens and later expanded to include viral antigens displayed on the surface of virus-infected cells, reflecting a shared biology underlying anti-tumor and anti-viral immunity. By assembling a team of scientific founders, experienced leadership, and an active board, it concentrates on advancing next-generation vaccines and related therapies. In the wider biopharma landscape, its programs target cancer and infectious-disease indications with the goal of expanding the reach of immunotherapy. A notable development in 2024 was the appointment of Stephen Webster to the board of directors.

Sign up for free to view info

Company overview Employee directory